ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD.

Altre lingue Zhejiang Jingxin Pharmaceutical Co., Ltd.

Azioni

002020

CNE000001K73

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 10/05/2024			Variaz. 5gg	Var. 1 gen.
12,07 ^CNY	-0,82%		+1,77%	-5,11%

23/04	Zhejiang Jingxin Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
29/03	Zhejiang Jingxin Pharmaceutical Co., Ltd. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04
Zhejiang Jingxin Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023	01/04
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Evotec Says Partner Obtained Regulatory Approval in China for Insomnia Drug	06/12
Aktien Frankfurt Eröffnung: Dax weiter auf Rekordkurs - Merck-Kursrutsch	06/12
Evotec-Partner Jingxin erhält Zulassung für EVT201 in China	06/12
Aktien Frankfurt Ausblick: Dax weiter auf Rekordjagd - Merck KGaA brechen ein	06/12
Jingxin Pharmaceutical Gets Nod to Market Didacinil Capsules	06/12
Evotec-Partner erhält Zulassung in China für Mittel gegen Schlafstörungen	06/12
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	14/08/23
Jingxin Pharma's Unit Gets Nod to Market Eye Drug in Europe	13/06/23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces 2022 Final Profit Distribution Plan, Payable on 24 May 2023	18/05/23
ExoRNA Bio announced that it has received funding from Guangzhou Yuexiu Industrial Investment Fund Management Co., Ltd., Zhejiang Jingxin Pharmaceutical Co., Ltd., Dingxin Capital Co., Ltd., CDH Investment Management Company Limited and other investors	15/05/23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2022	24/04/23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022	30/03/23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces Directorate Appointments	14/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Zhejiang Jingxin Pharmaceutical Co., Ltd.

Azioni

002020

CNE000001K73

Altre lingue

Filtri